{"id":2507448,"date":"2025-04-23T09:45:26","date_gmt":"2025-04-23T09:45:26","guid":{"rendered":"https:\/\/www.wacoca.com\/news\/2507448\/"},"modified":"2025-04-23T09:45:26","modified_gmt":"2025-04-23T09:45:26","slug":"%e8%a3%bd%e8%96%ac%e4%bc%81%e6%a5%ad%e5%90%91%e3%81%91-%e5%9b%bd%e9%9a%9b%e3%82%bb%e3%83%9f%e3%83%8a%e3%83%bc%ef%bd%9c%e3%82%a4%e3%82%ae%e3%83%aa%e3%82%b9%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8bin-vivo-2","status":"publish","type":"post","link":"https:\/\/www.wacoca.com\/news\/2507448\/","title":{"rendered":"\u88fd\u85ac\u4f01\u696d\u5411\u3051 \u56fd\u969b\u30bb\u30df\u30ca\u30fc\uff5c\u30a4\u30ae\u30ea\u30b9\u306b\u304a\u3051\u308bin vivo \u907a\u4f1d\u5b50\u7de8\u96c6\u30fb\u30b5\u30a4\u30ec\u30f3\u30b7\u30f3\u30b0\u533b\u85ac\u306e\u9032\u5c55\uff082025\u5e744\u670823\u65e5\uff09\uff5cBIGLOBE\u30cb\u30e5\u30fc\u30b9"},"content":{"rendered":"<p>        <img loading=\"lazy\" src=\"https:\/\/www.wacoca.com\/news\/wp-content\/uploads\/2025\/04\/d161163-1-f3f504cb43baf4ae3b08-0.png\" width=\"250\" height=\"122\" decoding=\"async\" alt=\"\"\/><\/p>\n<p>in vivo \u907a\u4f1d\u5b50\u7de8\u96c6\u30fb\u30b5\u30a4\u30ec\u30f3\u30b7\u30f3\u30b0\u533b\u85ac\u306e\u9032\u5c55\u3000\u2014 \u82f1\u56fd\u306b\u304a\u3051\u308b\u5e0c\u5c11\u75be\u60a3\u3068\u4e00\u822c\u75be\u60a3\u306e\u81e8\u5e8a\u7d4c\u9a13\u3092\u901a\u3058\u3066 \u2014<\/p>\n<p>\u3053\u306e\u305f\u3073\u3001\u907a\u4f1d\u5b50\u7de8\u96c6\u30fb\u907a\u4f1d\u5b50\u6cbb\u7642\u5206\u91ce\u3067\u4e16\u754c\u3092\u30ea\u30fc\u30c9\u3059\u308b\u82f1\u56fd\u306e\u6700\u65b0\u60c5\u5831\u304a\u3088\u3073\u3001\u3053\u306e\u30c6\u30fc\u30de\u306b\u304a\u3051\u308b\u65e5\u672c\u3068\u82f1\u56fd\u306e\u56fd\u969b\u9023\u643a\u3092\u30c6\u30fc\u30de\u3068\u3057\u305f\u30bb\u30df\u30ca\u30fc\u30a4\u30d9\u30f3\u30c8\u3092\u3001\u4e0b\u8a18\u306e\u901a\u308a\u958b\u50ac\u3059\u308b\u904b\u3073\u3068\u306a\u308a\u307e\u3057\u305f\u306e\u3067\u3054\u6848\u5185\u7533\u3057\u4e0a\u3052\u307e\u3059\u3002<\/p>\n<p>\u4e3b\u50ac\u8005\u3067\u3042\u308bRichmond Pharmacology\u306f\u3001\u9769\u65b0\u7684\u306a\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u5b9f\u73fe\u3092\u652f\u3048\u308b\u30a4\u30ae\u30ea\u30b9\u306eCRO\u3067\u3059\u3002Intellia\u793e\u3068\u306e\u5171\u540c\u8a66\u9a13\u3067\u306f\u3001ATTR\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u3092\u5bfe\u8c61\u3068\u3057\u305fCRISPR-Cas9\u6cbb\u7642\u85acNTLA-2001\u3092\u4e16\u754c\u3067\u521d\u3081\u3066\u60a3\u8005\u306b\u6295\u4e0e\u3057\u3001\u81e8\u5e8a\u958b\u767a\u53f2\u306b\u65b0\u305f\u306a\u4e00\u6b69\u3092\u523b\u307f\u307e\u3057\u305f\u3002<\/p>\n<p>\u672c\u30bb\u30df\u30ca\u30fc\u3067\u306f\u3001\u82f1\u56fd\u306e\u898f\u5236\u6a5f\u95a2\uff08MHRA\uff09\u304a\u3088\u3073\u533b\u7642\u73fe\u5834\uff08NHS\uff09\u3001\u81e8\u5e8a\u8a66\u9a13\u5b9f\u65bd\u6a5f\u95a2\uff08Richmond Pharmacology\uff09\u3001\u3055\u3089\u306b\u82f1\u56fd\u653f\u5e9c\u6a5f\u95a2\u3067\u907a\u4f1d\u5b50\u6cbb\u7642\u958b\u767a\u3092\u652f\u63f4\u3059\u308bCell &amp; Gene Catapult\u306e\u4ee3\u8868\u8005\u304c\u6765\u65e5\u3057\u3001\u82f1\u56fd\u304c\u4e16\u754c\u7684\u306b\u30ea\u30fc\u30c9\u3057\u3066\u3044\u308bin vivo\u907a\u4f1d\u5b50\u7de8\u96c6\u6cbb\u7642\u306e\u81e8\u5e8a\u8a66\u9a13\u306b\u3064\u3044\u3066\u3001\u6700\u65b0\u306e\u4e8b\u4f8b\u3068\u3068\u3082\u306b\u3054\u7d39\u4ecb\u3044\u305f\u3057\u307e\u3059\u3002<\/p>\n<p>\u65e5\u672c\u306e\u88fd\u85ac\u30fb\u30d0\u30a4\u30aa\u4f01\u696d\u306e\u7686\u69d8\u306b\u3068\u3063\u3066\u3001\u82f1\u56fd\u3067\u6cbb\u9a13\u3092\u5b9f\u65bd\u3059\u308b\u969b\u306e\u898f\u5236\u9762\u306e\u512a\u4f4d\u6027\u3001\u60a3\u8005\u30ea\u30af\u30eb\u30fc\u30c8\u30e1\u30f3\u30c8\u306e\u67d4\u8edf\u6027\u3001\u5148\u9032\u533b\u7642\u3078\u306e\u793e\u4f1a\u7684\u53d7\u5bb9\u6027\u306a\u3069\u3001**\u300c\u306a\u305c\u4eca\u3001\u82f1\u56fd\u306a\u306e\u304b\u300d**\u3068\u3044\u3046\u7591\u554f\u306b\u5bfe\u3059\u308b\u5b9f\u8df5\u7684\u306a\u30d2\u30f3\u30c8\u304c\u5f97\u3089\u308c\u308b\u5185\u5bb9\u3068\u306a\u3063\u3066\u304a\u308a\u307e\u3059\u3002<\/p>\n<p>\u307e\u305f\u3001\u30bb\u30df\u30ca\u30fc\u5185\u3067\u306f\u4ee5\u4e0b\u306e\u30c8\u30d4\u30c3\u30af\u306b\u3064\u3044\u3066\u3082\u30ab\u30d0\u30fc\u3059\u308b\u4e88\u5b9a\u3067\u3059\uff1a<br \/>&#13;<br \/>\n<br \/>&#13;<br \/>\n&#13;<br \/>\n&#13;<br \/>\n<br \/>&#13;<br \/>\n&#13;<br \/>\n\u8fc5\u901f\u306a\u6cbb\u9a13\u5b9f\u73fe\u3078 &#8211; Faster Answers\u306e\u5b9f\u4f8b\u7d39\u4ecb<br \/>MHRA\u306e\u8996\u70b9\uff1a\u5148\u9032\u533b\u7642\u5206\u91ce\u306b\u304a\u3051\u308b\u7814\u7a76\u652f\u63f4\u4f53\u5236<br \/>\u826f\u597d\u304b\u3064\u4fe1\u983c\u6027\u306e\u9ad8\u3044\u898f\u5236\u74b0\u5883\u306b\u3064\u3044\u3066<br \/>\u82f1\u56fd\u306e\u591a\u69d8\u306a\u60a3\u8005\u5c64\u3068\u30ea\u30af\u30eb\u30fc\u30c8\u30e1\u30f3\u30c8<br \/>\u907a\u4f1d\u5b50\u89e3\u6790\u306b\u5bfe\u3059\u308b\u793e\u4f1a\u7684\u7406\u89e3\u3068\u524d\u5411\u304d\u306a\u59ff\u52e2<\/p>\n<p>\u30a4\u30d9\u30f3\u30c8\u306e\u6700\u5f8c\u306b\u30cd\u30c3\u30c8\u30ef\u30fc\u30ad\u30f3\u30b0\u306e\u6642\u9593\u3082\u8a2d\u3051\u3066\u304a\u308a\u307e\u3059\u306e\u3067\u3001<br \/>\u53c2\u52a0\u8005\u30fb\u8b1b\u6f14\u8005\u9593\u3067\u306e\u60c5\u5831\u4ea4\u63db\u3084\u9023\u643a\u306e\u6a5f\u4f1a\u3068\u3057\u3066\u3082\u3054\u6d3b\u7528\u3044\u305f\u3060\u3051\u308c\u3070\u5e78\u3044\u3067\u3059\u3002<br \/>[\u753b\u50cf: https:\/\/prcdn.freetls.fastly.net\/release_image\/161163\/1\/161163-1-d5c6ea1295d14a3c93d61fb1c80aaf6a-920&#215;450.png?width=536&amp;quality=85%2C75&amp;format=jpeg&amp;auto=webp&amp;fit=bounds&amp;bg-color=fff ]<\/p>\n<p>\u3010\u4f1a\u5834\u3011\u3000\u65e5\u672c\u6a4b\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u30cf\u30d6 A\u4f1a\u8b70\u5ba4<br \/>\u3010\u4f4f\u6240\u3011\u3000\u6771\u4eac\u90fd\u4e2d\u592e\u533a\u65e5\u672c\u6a4b\u5ba4\u753a1\u4e01\u76ee5\u22125 \u5ba4\u753a\u3061\u3070\u304e\u3093\u4e09\u4e95\u30d3\u30eb\u30c7\u30a3\u30f3\u30b08\u968e<br \/>\u3010\u5730\u56f3\u3011\u3000https:\/\/maps.app.goo.gl\/DuXdYFkPjkC7xJsk7 \uff08Google Map\u304c\u958b\u304d\u307e\u3059\uff09<br \/>\u3010\u53c2\u52a0\u8cbb\u3011\u7121\u6599<br \/>\u3010\u5b9a\u54e1\u3011\u3000100\u540d\uff08\u5b9a\u54e1\u3068\u306a\u308a\u6b21\u7b2c\u3001\u52df\u96c6\u3092\u6253\u3061\u5207\u3089\u305b\u3066\u3044\u305f\u3060\u304d\u307e\u3059\uff09<br \/>\u3000\u3000\u3000\u3000\u3000https:\/\/richmond2025japan.peatix.com\/<\/p>\n<p>\u3010\u53d7\u4ed8\u3011\u30002025\u5e745\u670830\u65e5\uff08\u91d1\uff0918:00\u307e\u3067<br \/>\u3010\u4e3b\u50ac\u3011\u3000Richmond Pharmacology Limited<br \/>\u3010\u5171\u50ac\u3011\u3000\u307e\u3054\u306d\u3053\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u30ba\u682a\u5f0f\u4f1a\u793e<br \/>\u3010\u5354\u529b\u3011\u3000\u5728\u65e5\u82f1\u56fd\u5927\u4f7f\u9928 \/ MHRA \/ Cell and Gene Therapy Catapult<br \/>\u3010\u4e3b\u306a\u30c8\u30d4\u30c3\u30af\u3011<br \/>\u3000\u30fb\u8fc5\u901f\u306a\u6cbb\u9a13\u5b9f\u73fe\u3078 &#8211; Faster Answers\u306e\u5b9f\u4f8b\u7d39\u4ecb<br \/>\u3000\u30fbMHRA\u306e\u8996\u70b9\uff1a\u5148\u9032\u533b\u7642\u5206\u91ce\u306b\u304a\u3051\u308b\u7814\u7a76\u652f\u63f4\u4f53\u5236<br \/>\u3000\u30fb\u826f\u597d\u304b\u3064\u4fe1\u983c\u6027\u306e\u9ad8\u3044\u898f\u5236\u74b0\u5883\u306b\u3064\u3044\u3066<br \/>\u3000\u30fb\u82f1\u56fd\u306e\u591a\u69d8\u306a\u60a3\u8005\u5c64\u3068\u30ea\u30af\u30eb\u30fc\u30c8\u30e1\u30f3\u30c8<br \/>\u3000\u30fb\u907a\u4f1d\u5b50\u89e3\u6790\u306b\u5bfe\u3059\u308b\u793e\u4f1a\u7684\u7406\u89e3\u3068\u524d\u5411\u304d\u306a\u59ff\u52e2<br \/>\u203b\u9589\u4f1a\u5f8c\u3001\u767b\u58c7\u8005\u3068\u306e\u60c5\u5831\u4ea4\u63db\u4f1a\u3092\u958b\u50ac\u3044\u305f\u3057\u307e\u3059\uff081\u6642\u9593\u7a0b\u5ea6\uff09<\/p>\n<p>\u3010\u767b\u58c7\u8005\u3011\uff08\u9806\u4e0d\u540c\uff09\u203b\u767b\u58c7\u8005\u306f\u6025\u907d\u5909\u66f4\u3068\u306a\u308b\u5834\u5408\u304c\u3054\u3056\u3044\u307e\u3059\u3002<br \/>Dr. Jorg Taubel (Richmond Pharmacology)<br \/>Dr. Jacqueline Barry (C&gt;Catapult Representative)<br \/>Marie-Claire Joyce (\u5728\u65e5\u82f1\u56fd\u5927\u4f7f\u9928)<br \/>Dr. Lisa Campbell (Richmond Pharmacology)<br \/>Dr. David Jones (MHRA)<br \/>\u73fe\u5728\u8abf\u6574\u4e2d (NHS\/Alnylam\/PMDA\/AMED)<\/p>\n<p>\u3010\u9023\u7d61\u5148\u3011\u3000<br \/>JapanBD@richmondpharmacology.com\uff08\u30ea\u30c3\u30c1\u30e2\u30f3\u30c9\u30bb\u30df\u30ca\u30fc\u4e8b\u52d9\u5c40\uff09<\/p>\n<p>\u3010\u30d7\u30ed\u30b0\u30e9\u30e0\u3011\u203b\u5185\u5bb9\u306f\u4e88\u544a\u306a\u304f\u5909\u66f4\u306b\u306a\u308b\u5834\u5408\u304c\u3054\u3056\u3044\u307e\u3059<br \/>14:00 &#8211; 14:10\u3000Welcome &amp; Opening Remarks<br \/>14:10 &#8211; 14:30\u3000Faster Clinical Development: The UK\u2019s Advantage for Japanese Biopharma<br \/>14:30 &#8211; 14:50\u3000Regulatory Pathways: How MHRA Supports Gene Editing &amp; Advanced Therapies<br \/>14:50 &#8211; 15:10\u3000Gene Editing in the UK: The Science, the Ecosystem, the Advantage<br \/>15:10 &#8211; 15:30\u3000Coffee Break &amp; Networking<br \/>15:30 &#8211; 16:10\u3000Panel Discussion: Overcoming Regulatory &amp; Operational Challenges in UK Clinical Trials<br \/>16:10 &#8211; 16:30\u3000The Business Case: Why Japanese Companies Should Run Gene Editing Trials in the UK<br \/>16:30 &#8211; 16:50\u3000Health &amp; Economic Impact of Gene Editing Trials in the UK<br \/>16:50 &#8211; 17:00\u3000Closing Remarks &amp; Next Steps<br \/>17:00 &#8211; 18:00\u3000Networking Reception<\/p>\n<p>\u30a4\u30d9\u30f3\u30c8\u304a\u7533\u3057\u8fbc\u307f :<br \/>https:\/\/richmond2025japan.peatix.com\/<\/p>\n","protected":false},"excerpt":{"rendered":"<p>in vivo \u907a\u4f1d\u5b50\u7de8\u96c6\u30fb\u30b5\u30a4\u30ec\u30f3\u30b7\u30f3\u30b0\u533b\u85ac\u306e\u9032\u5c55\u3000\u2014 \u82f1\u56fd\u306b\u304a\u3051\u308b\u5e0c\u5c11\u75be\u60a3\u3068\u4e00\u822c\u75be\u60a3\u306e\u81e8\u5e8a\u7d4c\u9a13\u3092\u901a\u3058\u3066 \u2014 \u3053\u306e\u305f\u3073\u3001\u907a\u4f1d\u5b50\u7de8\u96c6\u30fb\u907a\u4f1d\u5b50\u6cbb\u7642\u5206\u91ce\u3067\u4e16\u754c\u3092\u30ea\u30fc\u30c9\u3059\u308b\u82f1\u56fd\u306e\u6700\u65b0\u60c5\u5831\u304a\u3088\u3073\u3001\u3053\u306e\u30c6\u30fc\u30de\u306b\u304a\u3051\u308b\u65e5\u672c\u3068\u82f1\u56fd\u306e\u56fd<\/p>\n","protected":false},"author":2,"featured_media":2507449,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[784991],"tags":[18202,154659,13014,1470,25840,200,132672,49632,4313,25842,2817,11634,1669,10092],"class_list":{"0":"post-2507448","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-united-kingdom","8":"tag-uk","9":"tag-united-kingdom","10":"tag-vivo","11":"tag-1470","12":"tag-25840","13":"tag-200","14":"tag-132672","15":"tag-49632","16":"tag-4313","17":"tag-25842","18":"tag-2817","19":"tag-11634","20":"tag-1669","21":"tag-10092"},"share_on_mastodon":{"url":"https:\/\/wakoka.com\/@news\/114386641600361967","error":""},"_links":{"self":[{"href":"https:\/\/www.wacoca.com\/news\/wp-json\/wp\/v2\/posts\/2507448","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.wacoca.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wacoca.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wacoca.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wacoca.com\/news\/wp-json\/wp\/v2\/comments?post=2507448"}],"version-history":[{"count":0,"href":"https:\/\/www.wacoca.com\/news\/wp-json\/wp\/v2\/posts\/2507448\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.wacoca.com\/news\/wp-json\/wp\/v2\/media\/2507449"}],"wp:attachment":[{"href":"https:\/\/www.wacoca.com\/news\/wp-json\/wp\/v2\/media?parent=2507448"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wacoca.com\/news\/wp-json\/wp\/v2\/categories?post=2507448"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wacoca.com\/news\/wp-json\/wp\/v2\/tags?post=2507448"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}